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The transglycosylation activity of a novel commercial β-galactosidase from 
Bifidobacterium bifidum (Saphera) was evaluated. The optimal conditions of operation of 
this enzyme, measured with o-nitrophenyl-β-D-galactopyranoside, were 40 °C and pH 
around 6.0. Although at low lactose concentrations the character of this enzyme was 
basically hydrolytic, an increase of lactose concentration to 400 g/L resulted in a 
significant formation (107.2 g/L, 27% yield) of prebiotic galactooligosaccharides (GOS). 
The maximum amount of GOS was obtained at a lactose conversion of approximately 90%, 
which contrasts with other β-galactosidases, for which the highest GOS yield is achieved 
at 40-50% lactose conversion. Using HPAEC-PAD, semipreparative HPLC-HILIC, MS, 1D 
and 2D NMR, we determined the structure of most of the GOS synthesized by this enzyme. 
The main identified products were Gal-β(13)-Gal-β(14)-Glc  (3´-O-Beta-galactosyl-
lactose), Gal-β(1→6)-Glc (allolactose), Gal-β(13)-Glc (3-galactosyl-glucose), Gal-
β(1→3)-Gal (3-galactobiose) and the tetrasaccharide Gal-β(13)-Gal-β(13)-Gal-
β(14)-Glc. In general, the B. bifidum β-galactosidase showed a tendency to form β(13) 
linkages followed by β(16), and more scarcely β(14).  
 
Keywords: Galactooligosaccharides, Prebiotics, Transglycosylation, β-
Galactosidase, Bifidobacteria, Glycosidases.
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Beta-Galactosidases (Beta-D-galactoside galactohydrolases, EC 3.2.1.23) catalyze the 
hydrolysis of different oligosaccharides with a galactosyl moiety located at the 
nonreducing end.1,2 The dairy industry is taking advantage of this reaction to remove 
lactose from milk to obtain lactose-free products.3,4 Due to the high amount of people 
suffering from lactose intolerance, the demand for lactose-free products is steadily 
increasing.5 Apart from its hydrolytic activity, Beta-galactosidases are also able to catalyze 
transgalactosylation reactions in which lactose ‒or other carbohydrates‒ act as acceptor 
molecules of galactosyl units yielding  di-, tri, tetra- or even higher oligomers called 
galactooligosaccharides (GOS).6-9 GOS chemically resemble the oligosaccharides present 
in human milk (HMOS) ‒which are structurally more complex‒, and both families exhibit 
prebiotic properties.10-12 More precisely, they improve the gastrointestinal microbiota by 
promoting the growth and/or the activity of bifidobacteria and lactobacilli,13 which are 
regarded to have a beneficial effect on human health.14,15 In addition to their prebiotic 
activity, several studies describe that GOS are non-cariogenic, diminish the serum 
cholesterol level, prevent colon cancer, enhance the digestibility of milk and improve the 
lactose tolerance.16,17 Therefore, Beta-galactosidases from generally recognized as safe 
(GRAS) microorganisms have attracted the attention of the dairy industries for enriching 
their products with GOS and developing novel functional foods.13,18 According to their 
sequences and structures, most Beta-galactosidases belong to families GH1, GH2, GH35, 
GH42 and GH59 of glycosyl hydrolases.1,9 
The yield and the composition of the synthesized GOS are influenced by the source of the 
enzyme and several reaction parameters including lactose concentration, pH, 
temperature, and water activity.19-21 The percentage of GOS in the mixtures may vary in a 
wide range between 15-55 % (w/w) depending on such conditions.22-25 The health 
promoting properties of GOS depend on their chemical composition, structure and degree 
of polymerization, which are highly influenced by the origin of the β-galactosidase.10 The 
chemical structure of the synthesized oligosaccharides (number of hexose units, types of 
linkages between them and carbohydrate composition) may affect their fermentation 
pattern by probiotic bacteria in the human intestine.26,27 Apparently, GOS mixtures 
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synthesized by Beta-galactosidases from probiotic microorganisms are consumed faster 
by probiotic species than those produced by other Beta-galactosidases.28-30  
Bifidobacterium species are one of the most common organisms in the human 
gastrointestinal tract.30,31 It has been demonstrated that GOS produced by Beta-
galactosidases from Bifidobacterium species have a different structure and significantly 
higher prebiotic potential compared with commercial mixtures of GOS,28,32 probably due 
to the prevalence of β(13) and β(16) linkages,25 whilst β(14) and β(16) bonds 
prevail in commercial GOS.6,33 β-galactosidases from Bifidobacterium species typically 
belong to families GH2 and GH42.1,25 Interestingly, GOS synthesis catalyzed by β-
galactosidases from bifidobacteria is not inhibited by the presence of glucose or 
galactose,34,35 which are commonly recognized as inhibitors of other Beta-galactosidases.36 
A novel commercial β-galactosidase from Bifidobacterium bifidum (Saphera®) was 
recently released to the market for obtaining lactose-free products. At moderate lactose 
concentrations (as those typically found in milk, whey permeate, kephir, etc.), this enzyme 
is described to synthesize a low amount of GOS compared with other β-galactosidases. In 
the present work, we have demonstrated that this property can be modulated by 
controlling lactose concentration. A detailed chemical characterization of the synthesized 
GOS was also performed. Saphera is an easily available preparation, which could facilitate 
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MATERIALS AND METHODS  
 
Materials 
The commercial β-galactosidase Saphera® (Novozym 46091) from Bifidobacterium 
bifidum was kindly supplied by Novozymes A/S (Bagsværd, Denmark). Lactose and o-
nitrophenyl-Beta-D-galactopyranoside (ONPG) were from Sigma-Aldrich. The standards 
3-O-Beta-galactosyl-galactose (3-galactobiose), 4-O-Beta-galactosyl-galactose (4-
galactobiose), 6-O-Beta-galactosyl-galactose (6-galactobiose), 6-O-Beta-galactosyl-
glucose (allolactose) and 4’-O-Beta-galactosyl-lactose were from Carbosynth (Berkshire, 
UK). The rest of standards were synthesized following previous works developed in our 
laboratory.22,37,38 All other reagents and solvents were of the highest available purity and 
used as purchased.  
Determination of β-galactosidase activity  
The assay of β-galactosidase activity was performed using o-nitrophenyl-Beta-D-
galactopyranoside (ONPG) as substrate. The activity was measured at 40 ºC following o-
nitrophenol (ONP) release at 405 nm using a microplate reader (Versamax, Molecular 
Devices). The reaction was started by adding 10 L of the enzyme solution (properly 
diluted) to 190 L of 15 mM ONPG in 0.1 M phosphate buffer (pH 6.8). The increase of 
absorbance at 405 nm was followed continuously at 40 ºC during 5 min. The molar 
extinction coefficient of o-nitrophenol at pH 6.8 was 1627 M-1 cm-1. One unit of activity (U) 
was defined as that corresponding to the hydrolysis of 1 mol of ONPG per min under the 
above specified conditions.  
Optimum temperature and pH  
The optimum temperature for the β-galactosidase activity was determined by mixing 50 
µL of a properly diluted enzyme solution with 450 µL of 15 mM ONPG in 0.1 M phosphate 
buffer (pH 6.8). The mixture was incubated for 10 min at different temperatures between 
10 ºC and 70 ºC. The reaction was stopped by adding 500 µL of 0.4 M Na2CO3 and the 
absorbance at 405 nm was measured in endpoint mode using a microplate reader 
(Versamax, Molecular Devices). The optimum pH for the β-galactosidase activity was 
measured at 40 ºC by performing the enzyme assay at different pH values (between 2.0 
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and 9.0), under the conditions described above, measuring the slope of o-nitrophenol 
release with time. The molar extinction coefficient of o-nitrophenol for each pH was 
determined (pH 2.0, 378.65 M-1 cm -1; pH 3.0, 383.85 M-1 cm -1; pH 4.0, 441.98 M-1 cm -1; 
pH 5.0, 495.38 M-1 cm -1; pH 6.0, 661.65 M-1 cm -1; pH 7.0, 2043.5 M-1 cm -1; pH 8.0, 4397.83 
M-1 cm -1; pH 9.0, 4403 M-1 cm -1). To minimize the buffer effect, solutions of 15 mM ONPG 
were prepared using 0.1 M Britton & Robinson buffer,39 adjusted to the required pH. All 
the experiments were performed in triplicate and the error was expressed as the standard 
deviation of the three measurements. 
pH and thermal stability of β-galactosidase 
In order to evaluate the thermostability of the β-galactosidase, the enzyme was incubated 
in 0.1 M phosphate buffer pH 6.8 for 1 hour at different temperatures ranging from 4 ˚C to 
70 ˚C. The remaining activity towards ONPG was determined by performing enzymatic 
activity measurements as described above. The evaluation of the stability towards pH was 
performed incubating enzyme samples at 40 ˚C for 3 hours at various pH values (between 
pH 2.0 and pH 12.0) using the Britton & Robinson buffer. The remaining activity was 
measured as described above. 
Production of galactooligosaccharides from lactose  
Lactose (400 g/L 34.7% w/w) was dissolved in 20 mL of 0.1 M phosphate buffer (pH 6.0). 
The biocatalyst was then added to adjust the Beta-galactosidase activity in the reaction 
mixture to 1.5 U/mL (ONPG units). The mixture was incubated at 40C in an orbital shaker 
(Vortemp 1550) at 200 rpm. At different times, 750 μL aliquots were harvested from the 
reaction vessel. The enzyme was inactivated by incubating the samples in a Thermomixer 
(Eppendorf) for 10 min at 96 °C. Samples were then filtered using micro-centrifuge filter 
tubes, with 0.45 m cellulose acetate filters (National Scientific) at 4000 x g for 5 min. The 
samples were diluted with water (1:400 and 1:4000) and then analyzed using HPAEC-
PAD. 
HPAEC-PAD analysis 
Products were analyzed by high-performance anion-exchange chromatography with 
pulsed amperometric detection (HPAEC-PAD) on a ICS3000 Dionex system (Dionex Corp., 
CA)  consisting of a SP gradient pump, an autosampler (model AS-HV) and an 
electrochemical detector with a gold working electrode and Ag/AgCl as reference 
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electrode. All eluents were degassed by flushing with helium. A pellicular anion-exchange 
4 x 250 mm Carbo-Pack PA-1 column (Dionex) connected to a 4 x 50 mm CarboPac PA-1 
guard column was used at 30 °C. Eluents were prepared with Milli-Q water and 50% (w/v) 
NaOH (Sigma-Aldrich). The initial mobile phase was 15 mM NaOH at 1.0 mL/min for 12 
min. A mobile phase gradient from 15 to 200 mM NaOH was performed in 15 min at 1.0 
mL/min, and it was maintained for 25 min. The peaks were analyzed by using Chromeleon 
software. The identification of the different carbohydrates was performed on the basis of 
commercially available standards or products purified in the laboratory. For those 
compounds whose standards were not available at sufficient amount, quantification was 
done based on the calibration curve of standards with the same degree of polymerization.  
Purification of GOS  
For the purification of unidentified GOS, the reaction was carried out as described above 
and stopped after 22 h by heating the solution for 10 min at 96 ºC to inactivate the 
biocatalyst. The reaction mixture was filtered using 0.45 µm paper filters and purified by 
semipreparative hydrophilic interaction chromatography (HPLC-HILIC). A quaternary 
pump (Delta 600, Waters) coupled to a Lichrosorb-NH2 column (5 m, 10 x 250 mm, 
Merck) was used. The column temperature was kept at 25 ºC. The acetonitrile/water 
75/25 (v/v) mobile phase was conditioned with helium and used as at a flow-rate of 6.25 
mL/min for 43 min. Peaks were detected by using an evaporative light-scattering detector 
DDL-31 (Eurosep) equilibrated at 60 C. A three-way flow splitter (model Accurate, 
Dionex) and a fraction collector II (Waters) were employed. The fractions containing the 
main peaks were collected and the solvent was removed by rotary evaporation.  
Mass spectrometry 
The MS analysis of purified galactooligosaccharides was assessed using a mass 
spectrometer with hybrid QTOF analyzer (model QSTAR, Pulsar i, AB Sciex). The sample 
was analyzed by direct infusion and ionized by electrospray (with methanol containing 
1% of sodium iodide as ionizing phase) in positive reflector mode. 
Nuclear Magnetic Resonance (NMR) 
The structure of the oligosaccharides was determined by using a combination of 1D (1H, 
13C) and 2D (COSY, NOESY, TOCSY, HSQC, HSQC-TOCSY, HMBC) NMR techniques. The 
samples were dissolved in D2O, using TSP-d4 [3-(trimethylsilyl)propionic-2,2,3,3-d4 acid 
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sodium salt] as chemical shift reference. Chemical shifts were expressed in parts per 
million with respect to the 0 ppm point of TSP. The spectra were measured in a Bruker 
800 AVIII spectrometer equipped with a 4-channels cryo TCI probe, with gradients in the 
Z axis, at a temperature of 298K. For the 1H-13C heteronuclear correlations (HSQC, HQSC-
TOCSY, HMBC), values of 5 ppm and 1-2K points, for the 1H dimension, and 70 ppm and 
384 points for the 13C dimension, were used. For the 1H-1H homonuclear experiments 
(COSY, NOESY, ROESY), 5 ppm windows were used in both dimensions with a 1-2K x 384 
point matrix. For the NOESY experiments, mixing times of 500-600 ms were used. The 
spinlock time was set to 300 ms for ROESY and 60/100 ms for HSQC-TOCSY experiments. 
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RESULTS AND DISCUSSION 
 
Effect of pH and temperature on activity and stability of Bifidobacterium 
bifidum Beta-galactosidase  
The hydrolytic activity of commercial Bifidobacterium bifidum β-galactosidase (Saphera), 
measured with o-nitrophenyl-Beta-D-galactopyranoside (ONPG) as substrate, was 1506 ± 
0.1 U/mL, determined at 40 ºC and pH 6.8, which are the optimal conditions reported for 
several Beta-galactosidases from Bifidobacteria.34,35,40  
In order to determine the optimum conditions of operation of this novel enzymatic 
preparation, a series of activity assays were performed at a fixed pH value (6.8) and 
different temperatures. The optimum temperature of the Beta-galactosidase from B. 
bifidum (Saphera) was found to be 40 ˚C (Fig. 1a). Furthermore, the thermostability was 
analyzed measuring the residual activity the enzyme in 0.1 M phosphate buffer (pH 6.8) 
after 1 h incubation. The β-galactosidase showed a rapid inactivation at temperatures 
above 50 ˚C (Fig. 1b). The thermal stability was significantly lower than that reported for 
other related enzymes, such as β-glycosidases from Sulfolobus solfataricus and Pyrococcus 
furiosus.41 However, the β-galactosidase from B. bifidum showed a higher thermostability 
compared to Beta-galactosidases from other Bifidobacterium species like B. breve.25  
The optimum pH of this preparation was also studied (Fig. 2a). The highest activity with 
ONPG was obtained at in the range pH 5.7-6.4. Regarding the stability of the enzyme at 
different pH values, the results showed that the β-galactosidase displayed good stability 
in the pH range 5.0-10.0, after 3 hours of incubation at 40 ºC (Fig. 2b). At pH 3.0 and 11.0 
the inactivation of the enzyme was very fast. In this context, the Beta-galactosidase from 
Bifidobacterium breve was rapidly inactivated at pH 9.0.25 Our results fit well with those 
described by Tzortis et al. using whole cells of B. bifidum NCIMB 41171, for which the 
optimum pH and temperature were 6.8-7.0 and 40 ˚C, respectively.34 The related β-
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GOS specificity of B. bifidum Beta-galactosidase 
The ability of B. bifidum β-galactosidase to synthesize galactooligosaccharides (GOS) was 
assessed. First, we followed by HPAEC-PAD the hydrolysis of lactose at 160 g/L under the 
optimal conditions (pH 6.0, 40 °C). As shown in Fig. 3a, the main reaction catalyzed by this 
enzyme under these conditions was the hydrolysis. However, the formation of several 
transgalactosylation products was observed.  
We further increased the lactose concentration to 400 g/L to promote transfer reaction. 
The HPAEC-PAD chromatogram (Fig. 3b) showed at least 19 peaks of which numbers 1, 2 
and 5 corresponded to galactose, glucose and lactose, respectively. The main reaction 
products corresponded to peaks 10, 15 and 19. We were able to purify peaks 15 and 19 by 
semipreparative HILIC for their characterization. For peak 15, the major signal in the mass 
spectrum in positive mode (Fig. 4A) was at m/z 527.16, corresponding to the M+[Na]+ ion 
of a trisaccharide. The 1D and 2D NMR spectra indicated that the structure of the 
compound fitted well with the trisaccharide 3’-O-β-galactosyl-lactose [Gal-β(13)-Gal-
β(14)-Glc], which was previously identified and characterized in our laboratory 
studying the GOS synthesis with β-galactosidase from Aspergillus oryzae.22  
The main signal in the mass spectrum of peak 19 (Fig. 4B) was at m/z 689.21, 
corresponding to the M+[Na]+ ion of a tetrasaccharide. The 1H-NMR-based information for 
the major product of this peak was fairly similar to that recorded for peak 15, although it 
clearly displayed one additional anomeric proton (Figs. 5A and 5B). The analysis 
demonstrated that the Gal rings were not substituted at position 4, and only 3-Gal 
glycosylated moieties could be found. As for peak 15, the existing Glc ring was glycosylated 
position 4. Therefore, the structure of the compound was determined to be 3´-O-β-(3-
galactobiosyl)-lactose [Gal-β(13)-Gal-β(13)-Gal-β(14)-Glc] in a non-ambiguous 
manner. Fig. 5 shows the similarity of the 1H-NMR spectra of peaks 15 and 19. Both 
positions α- and β- at the reducing end were unambiguously identified for these 
compounds by the HSQC spectrum. 
Peaks 8 and 9 were identified as the trisaccharide 6’-O-Beta-galactosyl-lactose and the 
disaccharide 3-O-Beta-galactosyl-glucose, respectively, using purified standards from K. 
lactis Beta-galactosidase reactions.42 With commercial standards it was also possible to 
identify peak 12 as the trisaccharide 4’-O-Beta-galactosyl-lactose and several 
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disaccharides with different glycosidic bonds, involving two units of galactose (peak 3, 6-
galactobiose; peak 6, 3-galactobiose; peak 7, 4-galactobiose) or galactose-glucose (peak 4, 
Gal-β(16)-Glc, allolactose; peak 9, Gal-β(13)-Glc).  
One more reaction product (peak 13) was also partially purified by semipreparative HPLC. 
The mass spectrum showed that the main signal corresponded to a trisaccharide. Although 
the purity of this sample was not enough for a precise structure determination, the identity 
of the components of the mixture was further studied. From the NMR data, different 
glycosylation positions could be detected. For the Gal-Gal linkages, both Beta(13) and 
Beta(14) disaccharide fragments were found, with similar proportions. For the Gal-Glc 
linkages, the Beta(14) position was predominant, but minor Beta(13) as well as 
minute fractions of Beta(12) linked moieties were also detected. Therefore, the mixture 
within peak 13 is composed of the Gal-β(13)-Gal-β(14)-Glc and Gal-β(14)-Gal-
β(14)-Glc trisaccharides as major products, together with the Gal-β(13)-Gal-β(13)-
Glc, Gal-β(14)-Gal-β(13)-Glc analogues as minor components. Such assignations were 
performed on the basis of previous publications.43-46 Additionally, small amounts of 
products with the Glc moiety glycosylated at position 2 were present.  
In a recent paper, using the β-galactosidase activity from several Pantoea anthophila 
strains, we were able to identify peak 14 as 3’-O-galactosyl-allolactose (Gal-β(13)-Gal-
β(16)-Glc).47 Regarding peak 10, one of the most abundant in the GOS mixture, we 
believe that it could be composed by three galactosyl residues bound by β(13) linkages 
[Gal-β(13)-Gal-β(13)-Gal, 3-galactotriose]. This assumption is based on the enzyme 
specificity, the relative retention times and the presence of a significant amount of 3-
galactobiose, which could serve as galactosyl acceptor. However, we were not able to 
isolate it with enough purity for NMR analysis. Peaks 11, 16, 17 and 18 remained 
unidentified, but all of them were minor components of the mixture. 
Our results fit well with those obtained using other B. bifidum strains. Depeint et al.48 and 
Goulas et al.49 reported the presence of β(13) linkages, with less participation of β(14) 
and β(16) bonds, in the GOS mixture obtained with β-galactosidase from B. bifidum 
NCIMB41171. However, Rabiu et al. identified, in addition to β(13) linkages, several 
β(16) and  β(14) bonds.28 This partially agrees with our findings, but it is well studied 
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that there are more than one β-galactosidase in Bifidobacteria strains, and the synthesized 
oligosaccharides may vary.40,49 
Progress of GOS formation 
The progress of GOS formation was followed by HPAEC-PAD. Experimental conditions 
were 400 g/L lactose in 0.1 M sodium phosphate buffer (pH 6.0), 40 ºC and 1.5 U/mL 
(ONPG units). Table 1 shows the concentrations of the main reaction products at different 
times. Under the above conditions, the point of maximum GOS production (107.2 g/L, 27% 
of total sugars in the mixture) was obtained at 50.5 h. At this point, the rest of components 
in the mixture were glucose (38%), galactose (26%) and lactose (9%). It is worth noting 
that the time required to get the maximum GOS yield depends inversely on the amount of 
enzyme; however, as occurs in this kind of kinetically-controlled reactions,50-52 the GOS 
concentration at this point is not affected by the amount of biocatalyst. Rabiu et al. 
reported GOS yields between 24.7-47.6% employing 30% (w/w) lactose and five different 
species of bifidobacteria, including B. bifidum BB-12 (37.6% yield).28 Tzortzis et al. 
demonstrated that using whole-cells of B. bifidum NCIMB41171 the maximum GOS yield 
was 35% employing 55% (w/w) lactose.34 
At the point of maximum GOS concentration, the most abundant GOS corresponded to 3’-
galactosyl-lactose (17.7 g/L), allolactose (16.2 g/L), 3-O-β-galactosyl-glucose (9.0 g/L), 
and 3-galactobiose (8.2 g/L), apart from unidentified peak 10. These results confirm that 
the enzyme has a clear tendency to form β(13) linkages followed by β(16).  However, 
only a small proportion of products containing new β(14) linkages were observed. It is 
worth noting that the GOS synthesis using B. bifidum Beta-galactosidase resulted in a high 
amount of disaccharides (approx. 40.4 g/L), with allolactose, 3-O-Beta-galactosyl-glucose 
and 3-galactobiose as the main components of this fraction. In this context, Böger et al. 
recently reported that most probiotic strains of gut bacteria exhibited a preference for DP2 
galactooligosaccharides.53 
Fig. 6 represents the profile of GOS concentration as a function of lactose conversion. It is 
remarkable, compared with other β-galactosidases, that the GOS concentration increased 
progressively until 80% of initial lactose has disappeared. Then, the yield of GOS was 
nearly invariable until approximately 93% of lactose was consumed. These results 
contrast with those obtained with Bacillus circulans37 and Aspergillus oryzae22 β-
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galactosidases, for which the maximum concentration of GOS was achieved at 
approximately 40-50% of lactose conversion. Thereafter, GOS are hydrolyzed by the 
enzyme, in particular those containing β(14) linkages. The profile obtained with B. 
bifidum Beta-galactosidase resembles that of Kluyveromyces lactis lactase, as the maximum 
GOS yield was also achieved at approximately 95% of lactose conversion.42 In this context, 
Hsu et al., using a β-galactosidase from B. longum, reported a maximum GOS yield of 32.5%, 
which obtained at approximately 60% lactose conversion, and was followed by a 
hydrolysis of the synthesized GOS.35 
In conclusion, the commercial preparation Saphera gave rise to a moderate GOS yield 
(27%) compared with other Beta-galactosidases. However, the predominance of β(13) 
linkages in the synthesized GOS has several advantages with respect to other commercial 
GOS mixtures. First, the production of GOS with Saphera can be easily controlled because 
GOS hydrolysis only takes place when approximately 95% of the initial lactose has 
disappeared. Second, it has been reported that GOS containing β(13) bonds are 
metabolized by probiotic bacteria faster than similar GOS containing other linkages, in 
particular β(14).29 There is a general consensus that GOS synthetized with β-





GOS, galactooligosaccharides; HMOS, human milk oligosaccharides; ONPG, o-nitrophenyl-
β-D-galactopyranoside; GRAS, generally recognized as safe; HPAEC-PAD, high-
performance anion-exchange chromatography with pulsed amperometric detection; 
HPLC, high-performance liquid chromatography; HILIC, hydrophilic interaction liquid 
chromatography; MS, mass spectrometry; QTOF, quadrupole time of flight; NMR, nuclear 
magnetic resonance; COSY, correlation spectroscopy; NOESY, nuclear overhauser effect 
spectroscopy ; TOCSY, total correlation spectroscopy;  HSQC, heteronuclear single 
quantum correlation; HMBC, heteronuclear multiple bond correlation; TSP-d4,  3-
(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt; DP, degree of polymerization. 
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Figure 1:  Effect of temperature on a) activity and b) stability of β-galactosidase from B. 
bifidum. For the activity assay, 0.1 M phosphate buffer (pH 6.8) was used. For the 
thermostability assay, the enzyme was incubated in the same buffer at different 
temperatures for 1 h. Residual activity was referred to the initial activity of the enzyme. 
Figure 2: Effect of pH on a) activity and b) stability of β-galactosidase from B. bifidum. For 
the activity assay, 0.1 M Britton & Robinson buffer at different pH was used and the activity 
measured at 40 ˚C. For the stability assay, the enzyme solution was incubated under 
different pH values at 40 ˚C for 3 h. Residual activity was referred to the initial activity of 
the enzyme. 
Figure 3: HPAEC-PAD analysis (22 h) of the reaction of lactose with B. bifidum β-
galactosidase (Saphera) under optimal conditions (pH 6.0, 40 °C) at two lactose 
concentrations: a) 160 g/L; b) 400 g/L. Peaks assignation: (1) Galactose; (2) Glucose; (3) 
6-Galactobiose; (4) Allolactose; (5) Lactose; (6) 3-Galactobiose; (7) 4-Galactobiose; (8) 6’-
Galactosyl-lactose; (9) 3-O-β-Galactosyl-glucose; (12) 4´-Galactosyl-lactose; (13) Gal-
β(13)-Gal-β(13)-Glc; (14) 3’-Galactosyl-allolactose; (15) 3´-Galactosyl-lactose; (19) 
3´-O-β-(3-Galactobiosyl)-lactose; (10,11,16-18) unidentified. 
Figure 4: ESI-TOF mass spectra (positive mode) of: A) Peak 15; B) Peak 19. 
Figure 5: 1H-NMR spectra of the reaction products corresponding to peaks 13, 15 and 19. 
The major product for peak 19 (A) corresponds to the tetrasaccharide Gal-β(1→3)-Gal-
β(1→3)-Gal-β(1→4)-Glc(α/β). For peak 15 (B) the major product is Gal-β(1→3)-Gal-
β(1→4)-Glc(α/β). For peak 13 (C) a mixture of trisaccharides (according to MS) containing 
all the possibilities for Gal-β(1→3/1→4)-Gal-β(1→4/1→3/1→2)-Glc(α/β) is obtained. For 
the three peaks, small amounts of oligosaccharides with the reducing Glc residue 
glycosylated at position 2 have been found (signals at 5.4-5.5 ppm). 
Figure 6: GOS formation vs. lactose conversion using β-galactosidase from B. bifidum 
(Saphera). Experimental conditions: 400 g/L lactose in 0.1 M sodium phosphate buffer (pH 
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Figure 2         Go back to Fig. 2
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Figure 5        Go back to Fig. 5
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Table 1. Carbohydrate composition (g/L) of the reaction mixture using β-
galactosidase from B. bifidum (Saphera). Experimental conditions: 400 g/L lactose 










































0 0.0 0.0 400.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
10 4.1 4.6 390.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 
20 6.6 8.0 382.7 0.0 0.0 0.0 0.0 0.1 0.6 1.6 0.1 0.3 2.7 
30 9.7 11.6 374.9 0.0 0.0 0.0 0.0 0.3 0.7 2.3 0.1 0.4 3.8 
60 16.1 20.8 355.8 0.0 0.0 0.0 0.0 0.8 1.3 3.8 0.3 1.2 7.3 
120 25.4 33.0 326.9 0.0 0.0 0.1 0.1 2.2 2.0 6.6 0.8 3.0 14.7 
180 30.6 41.7 306.1 0.0 0.0 0.0 0.2 3.8 2.5 8.7 1.2 5.2 21.6 
240 34.6 49.1 285.3 0.0 0.0 0.2 0.3 6.0 3.3 11.2 1.9 8.1 31.0 
300 38.8 55.3 272.4 0.0 0.0 0.2 0.4 6.5 3.2 11.8 2.2 9.2 33.5 
390 40.9 59.6 241.4 0.0 0.6 0.4 0.5 7.6 3.5 12.2 2.6 30.7 58.1 
1320 74.1 117.5 117.5 1.1 4.8 3.2 2.3 12.1 4.7 20.8 6.3 35.6 90.9 
1830 84.6 131.2 78.2 1.4 7.5 4.6 3.2 13.4 4.1 20.7 7.1 44.0 105.9 
3030 103.4 152.0 37.4 2.2 16.2 8.2 4.8 9.0 2.6 17.7 5.4 41.1 107.2 
4200 109.2 158.8 27.7 2.8 23.3 10.9 5.5 7.9 1.8 12.2 3.5 36.3 104.3 
Gal: Galactose; Glc: Glucose; Lact: Lactose; Gal-6-Gal: 6-galactobiose; Gal-6-Glc: Allolactose; Gal-3-Gal: 3-
galactobiose; Gal-4-Gal: 4-galactobiose; Gal-3-Glc: 3-galactosyl-glucose; Gal-4-Lact: 4’-galactosyl-lactose; Gal-3-
Lact: 3’-galactosyl-lactose; Gal-3-Gal-3-Lact: 3´-(3-galactobiosyl)-lactose; GOSTOT: Total GOS in the mixture 
Go back to Table 1 
 
